
Peregrine Ventures sells 30 per cent of Neovasc holdings to Fidelity for USD12m
Israeli venture capital fund Peregrine Ventures has sold around 30 per cent of its holdings in medical devices company Neovasc Inc to the investment firm Fidelity Select Portfolios: Medical Equipment & Systems Portfolio, for USD12 million. Peregrine sold two million of the 6.7 million Neovasc shares it held at USD6.00



